| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 43 | 2023 | 43 | 8.530 |
Why?
|
| NADH, NADPH Oxidoreductases | 19 | 2023 | 19 | 3.390 |
Why?
|
| Multienzyme Complexes | 18 | 2021 | 30 | 3.330 |
Why?
|
| beta-Glucans | 19 | 2022 | 24 | 3.120 |
Why?
|
| Schistosomicides | 11 | 2023 | 11 | 2.870 |
Why?
|
| Candida albicans | 16 | 2023 | 19 | 2.550 |
Why?
|
| Animals | 78 | 2023 | 3551 | 2.400 |
Why?
|
| Glucans | 9 | 2022 | 9 | 2.300 |
Why?
|
| Helminth Proteins | 12 | 2015 | 12 | 2.260 |
Why?
|
| Mannans | 11 | 2022 | 13 | 2.180 |
Why?
|
| Enzyme Inhibitors | 11 | 2020 | 114 | 1.890 |
Why?
|
| Macrophages | 11 | 2022 | 101 | 1.890 |
Why?
|
| Schistosomiasis mansoni | 13 | 2018 | 13 | 1.800 |
Why?
|
| Schistosomiasis | 6 | 2023 | 7 | 1.640 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 136 | 1.440 |
Why?
|
| Cell Wall | 9 | 2022 | 9 | 1.400 |
Why?
|
| Mice | 34 | 2023 | 1380 | 1.380 |
Why?
|
| Immunity, Innate | 9 | 2022 | 56 | 1.320 |
Why?
|
| Aminoacyltransferases | 3 | 2013 | 3 | 1.230 |
Why?
|
| Oxidation-Reduction | 15 | 2023 | 64 | 1.170 |
Why?
|
| Anthelmintics | 6 | 2020 | 8 | 1.060 |
Why?
|
| Lectins, C-Type | 17 | 2022 | 46 | 0.980 |
Why?
|
| Membrane Proteins | 10 | 2009 | 159 | 0.980 |
Why?
|
| Molecular Sequence Data | 21 | 2013 | 185 | 0.980 |
Why?
|
| Nerve Tissue Proteins | 9 | 2009 | 153 | 0.920 |
Why?
|
| Recombinant Proteins | 13 | 2017 | 204 | 0.830 |
Why?
|
| Malassezia | 2 | 2015 | 2 | 0.830 |
Why?
|
| Peroxiredoxins | 10 | 2021 | 11 | 0.780 |
Why?
|
| Amino Acid Sequence | 16 | 2013 | 146 | 0.770 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2015 | 20 | 0.760 |
Why?
|
| Drug Design | 4 | 2012 | 23 | 0.740 |
Why?
|
| Peroxidases | 4 | 2006 | 7 | 0.720 |
Why?
|
| Ancylostoma | 3 | 2019 | 3 | 0.710 |
Why?
|
| Thioredoxin-Disulfide Reductase | 8 | 2023 | 8 | 0.690 |
Why?
|
| Membrane Glycoproteins | 3 | 2013 | 68 | 0.670 |
Why?
|
| Hyphae | 2 | 2013 | 2 | 0.660 |
Why?
|
| Oxidative Stress | 5 | 2015 | 106 | 0.640 |
Why?
|
| Gene Expression Regulation | 8 | 2022 | 269 | 0.640 |
Why?
|
| DNA, Helminth | 6 | 2013 | 6 | 0.630 |
Why?
|
| Gene Expression | 4 | 2020 | 196 | 0.610 |
Why?
|
| Fungal Polysaccharides | 2 | 2018 | 2 | 0.600 |
Why?
|
| Immunomodulation | 1 | 2017 | 7 | 0.590 |
Why?
|
| Auranofin | 7 | 2022 | 7 | 0.580 |
Why?
|
| Immunologic Factors | 1 | 2017 | 33 | 0.570 |
Why?
|
| Cytokines | 9 | 2020 | 224 | 0.560 |
Why?
|
| Antigens, Helminth | 4 | 2007 | 4 | 0.560 |
Why?
|
| Biological Products | 1 | 2017 | 38 | 0.550 |
Why?
|
| Phytochelatins | 2 | 2013 | 2 | 0.540 |
Why?
|
| Albumins | 2 | 2006 | 17 | 0.530 |
Why?
|
| Polysaccharides | 5 | 2013 | 12 | 0.520 |
Why?
|
| Humans | 45 | 2023 | 26260 | 0.520 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 2 | 0.510 |
Why?
|
| Candidiasis | 5 | 2020 | 19 | 0.500 |
Why?
|
| Oxadiazoles | 3 | 2014 | 8 | 0.500 |
Why?
|
| NADP | 4 | 2023 | 9 | 0.500 |
Why?
|
| Schistosoma | 3 | 2023 | 3 | 0.470 |
Why?
|
| Fungal Proteins | 3 | 2013 | 6 | 0.460 |
Why?
|
| Parasitology | 2 | 2011 | 2 | 0.460 |
Why?
|
| High-Throughput Screening Assays | 3 | 2020 | 6 | 0.460 |
Why?
|
| Monocytes | 4 | 2020 | 60 | 0.450 |
Why?
|
| Male | 22 | 2021 | 14168 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 420 | 0.440 |
Why?
|
| Geranyltranstransferase | 1 | 2013 | 1 | 0.440 |
Why?
|
| Diphosphonates | 1 | 2013 | 17 | 0.430 |
Why?
|
| Cell Line | 7 | 2017 | 262 | 0.430 |
Why?
|
| Adjuvants, Immunologic | 3 | 2022 | 13 | 0.420 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2013 | 37 | 0.420 |
Why?
|
| Ovum | 2 | 2015 | 3 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2019 | 30 | 0.410 |
Why?
|
| Cestode Infections | 1 | 2012 | 1 | 0.410 |
Why?
|
| Platyhelminths | 1 | 2012 | 1 | 0.410 |
Why?
|
| Glutathione | 7 | 2023 | 21 | 0.410 |
Why?
|
| Cloning, Molecular | 7 | 2011 | 27 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 116 | 0.400 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 73 | 0.390 |
Why?
|
| Thioredoxins | 5 | 2023 | 7 | 0.380 |
Why?
|
| Female | 20 | 2023 | 14520 | 0.380 |
Why?
|
| Immunologic Memory | 2 | 2022 | 24 | 0.380 |
Why?
|
| Biocatalysis | 1 | 2011 | 1 | 0.380 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 50 | 0.370 |
Why?
|
| Phagocytosis | 5 | 2021 | 40 | 0.370 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 48 | 0.370 |
Why?
|
| Models, Molecular | 7 | 2018 | 62 | 0.360 |
Why?
|
| Disulfides | 3 | 2023 | 11 | 0.360 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 35 | 0.360 |
Why?
|
| Life Cycle Stages | 3 | 2011 | 5 | 0.360 |
Why?
|
| B-Lymphocytes | 5 | 2022 | 51 | 0.350 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 4 | 0.340 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 178 | 0.340 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2018 | 54 | 0.330 |
Why?
|
| Candida | 2 | 2020 | 11 | 0.330 |
Why?
|
| Signal Transduction | 9 | 2022 | 417 | 0.330 |
Why?
|
| Dendritic Cells | 5 | 2021 | 32 | 0.330 |
Why?
|
| Glutathione Reductase | 4 | 2023 | 5 | 0.330 |
Why?
|
| Reactive Oxygen Species | 7 | 2023 | 111 | 0.310 |
Why?
|
| Receptors, Cell Surface | 3 | 2009 | 37 | 0.310 |
Why?
|
| Sequence Alignment | 6 | 2013 | 21 | 0.310 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2020 | 6 | 0.300 |
Why?
|
| Praziquantel | 3 | 2023 | 4 | 0.300 |
Why?
|
| Naphthoquinones | 3 | 2015 | 5 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2013 | 38 | 0.290 |
Why?
|
| Carbohydrate Conformation | 4 | 2013 | 6 | 0.290 |
Why?
|
| Protein Binding | 4 | 2017 | 118 | 0.290 |
Why?
|
| Candida glabrata | 2 | 2021 | 3 | 0.280 |
Why?
|
| Gold | 2 | 2020 | 2 | 0.280 |
Why?
|
| Proteome | 1 | 2007 | 41 | 0.280 |
Why?
|
| Receptors, Immunologic | 3 | 2005 | 28 | 0.270 |
Why?
|
| Kinetics | 5 | 2013 | 158 | 0.270 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2006 | 3 | 0.270 |
Why?
|
| Leukocytes | 1 | 2006 | 36 | 0.260 |
Why?
|
| Inflammation | 5 | 2023 | 264 | 0.250 |
Why?
|
| Molecular Weight | 4 | 2011 | 29 | 0.240 |
Why?
|
| Escherichia coli | 4 | 2013 | 52 | 0.240 |
Why?
|
| Intestinal Absorption | 1 | 2005 | 36 | 0.240 |
Why?
|
| Neutrophils | 2 | 2021 | 89 | 0.240 |
Why?
|
| Solubility | 6 | 2022 | 26 | 0.240 |
Why?
|
| Biomphalaria | 3 | 2009 | 3 | 0.240 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 78 | 0.240 |
Why?
|
| Brugia malayi | 2 | 2022 | 2 | 0.230 |
Why?
|
| Onchocerca volvulus | 2 | 2022 | 2 | 0.230 |
Why?
|
| Drug Discovery | 3 | 2020 | 14 | 0.230 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 14 | 0.230 |
Why?
|
| Proteins | 2 | 2021 | 64 | 0.220 |
Why?
|
| Antimalarials | 2 | 2015 | 7 | 0.220 |
Why?
|
| Open Reading Frames | 2 | 2015 | 9 | 0.220 |
Why?
|
| Drug Resistance | 2 | 2015 | 42 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 18 | 0.220 |
Why?
|
| Nitric Oxide Donors | 3 | 2014 | 7 | 0.220 |
Why?
|
| Phylogeny | 5 | 2012 | 40 | 0.220 |
Why?
|
| Spores, Fungal | 1 | 2003 | 1 | 0.220 |
Why?
|
| Immunity | 2 | 2020 | 15 | 0.220 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 6 | 0.220 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 1 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2021 | 298 | 0.210 |
Why?
|
| Candidiasis, Invasive | 1 | 2023 | 1 | 0.210 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2023 | 4 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 5 | 2013 | 57 | 0.210 |
Why?
|
| Adenylosuccinate Lyase | 1 | 2002 | 1 | 0.210 |
Why?
|
| Cysteine | 4 | 2022 | 8 | 0.210 |
Why?
|
| Substrate Specificity | 3 | 2013 | 20 | 0.200 |
Why?
|
| Receptors, LDL | 1 | 2002 | 3 | 0.200 |
Why?
|
| Receptors, Pattern Recognition | 3 | 2022 | 5 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2002 | 9 | 0.200 |
Why?
|
| Parasites | 1 | 2022 | 1 | 0.200 |
Why?
|
| Antigens, Viral | 1 | 2022 | 9 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2021 | 129 | 0.200 |
Why?
|
| Host-Parasite Interactions | 3 | 2012 | 3 | 0.190 |
Why?
|
| Communicable Diseases | 1 | 2022 | 23 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 10 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 60 | 0.190 |
Why?
|
| Sepsis | 1 | 2003 | 136 | 0.190 |
Why?
|
| Polymers | 2 | 2020 | 39 | 0.190 |
Why?
|
| Immune Evasion | 1 | 2021 | 2 | 0.190 |
Why?
|
| Cells, Cultured | 7 | 2018 | 505 | 0.190 |
Why?
|
| Antiparasitic Agents | 1 | 2021 | 1 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 82 | 0.190 |
Why?
|
| Hydrogen Peroxide | 4 | 2008 | 44 | 0.180 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2011 | 290 | 0.180 |
Why?
|
| Mice, Inbred ICR | 3 | 2006 | 12 | 0.180 |
Why?
|
| Nanostructures | 1 | 2021 | 10 | 0.180 |
Why?
|
| Helminthiasis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Protozoan Infections | 1 | 2020 | 1 | 0.180 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 8 | 0.180 |
Why?
|
| Coordination Complexes | 1 | 2020 | 2 | 0.180 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cell Plasticity | 1 | 2020 | 1 | 0.170 |
Why?
|
| Respirovirus Infections | 1 | 2020 | 2 | 0.170 |
Why?
|
| Artemia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Germ-Free Life | 1 | 2020 | 1 | 0.170 |
Why?
|
| Expressed Sequence Tags | 3 | 2007 | 5 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 53 | 0.170 |
Why?
|
| Selenocysteine | 3 | 2011 | 3 | 0.170 |
Why?
|
| Oviposition | 1 | 2019 | 3 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 338 | 0.160 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 15 | 0.160 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 84 | 0.150 |
Why?
|
| Crystallography, X-Ray | 5 | 2019 | 11 | 0.150 |
Why?
|
| Toll-Like Receptor 2 | 4 | 2009 | 31 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 134 | 0.150 |
Why?
|
| Ligands | 3 | 2022 | 35 | 0.150 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 1 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 105 | 0.150 |
Why?
|
| Neoplasms | 1 | 2020 | 224 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 37 | 0.150 |
Why?
|
| Protein Conformation | 3 | 2013 | 60 | 0.150 |
Why?
|
| Virulence | 3 | 2023 | 10 | 0.140 |
Why?
|
| Base Sequence | 4 | 2006 | 100 | 0.140 |
Why?
|
| Computational Biology | 3 | 2012 | 20 | 0.140 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 55 | 0.140 |
Why?
|
| Nitric Oxide | 3 | 2014 | 77 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 38 | 0.140 |
Why?
|
| Organ Specificity | 3 | 2022 | 40 | 0.130 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 19 | 0.130 |
Why?
|
| Molecular Structure | 4 | 2014 | 17 | 0.130 |
Why?
|
| Introns | 3 | 2009 | 16 | 0.130 |
Why?
|
| Transfection | 2 | 2008 | 111 | 0.130 |
Why?
|
| Neutrophil Activation | 1 | 2015 | 7 | 0.120 |
Why?
|
| Rats | 3 | 2009 | 634 | 0.120 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 29 | 0.120 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2015 | 1 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 34 | 0.120 |
Why?
|
| Erythrocytes | 1 | 2015 | 20 | 0.120 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.120 |
Why?
|
| Microfilariae | 1 | 2015 | 2 | 0.120 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 2 | 0.120 |
Why?
|
| Loiasis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2007 | 33 | 0.120 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 15 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 1 | 2014 | 9 | 0.120 |
Why?
|
| Culture Media | 2 | 2011 | 28 | 0.120 |
Why?
|
| Blood | 2 | 2011 | 18 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2014 | 11 | 0.120 |
Why?
|
| Pyrazines | 1 | 2014 | 8 | 0.120 |
Why?
|
| Temperature | 2 | 2011 | 56 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2007 | 26 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2022 | 35 | 0.120 |
Why?
|
| Gene Library | 2 | 2007 | 7 | 0.110 |
Why?
|
| S-Nitrosothiols | 1 | 2014 | 1 | 0.110 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 1 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 328 | 0.110 |
Why?
|
| Epitopes | 2 | 2022 | 48 | 0.110 |
Why?
|
| Ancylostomiasis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Biomarkers | 3 | 2022 | 556 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 101 | 0.110 |
Why?
|
| Genome, Helminth | 2 | 2012 | 2 | 0.110 |
Why?
|
| Mannose | 1 | 2013 | 2 | 0.110 |
Why?
|
| Mannosyltransferases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2013 | 6 | 0.110 |
Why?
|
| Retroelements | 2 | 2003 | 3 | 0.110 |
Why?
|
| Peptidyl Transferases | 1 | 2013 | 1 | 0.110 |
Why?
|
| Xenobiotics | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hydrolases | 1 | 2013 | 4 | 0.110 |
Why?
|
| Proteomics | 1 | 2014 | 92 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 1 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 11 | 0.100 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mammals | 2 | 2023 | 23 | 0.100 |
Why?
|
| Quinolines | 1 | 2012 | 7 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 330 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2012 | 39 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2003 | 144 | 0.100 |
Why?
|
| Precipitin Tests | 2 | 2002 | 10 | 0.100 |
Why?
|
| Liver | 2 | 2023 | 154 | 0.100 |
Why?
|
| Antifungal Agents | 2 | 2023 | 28 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2012 | 45 | 0.090 |
Why?
|
| Lung | 2 | 2022 | 148 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 94 | 0.090 |
Why?
|
| Metals | 1 | 2013 | 150 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 9 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 15 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 17 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 9 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 7 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 8 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 14 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 349 | 0.090 |
Why?
|
| Methionine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 29 | 0.080 |
Why?
|
| Time Factors | 2 | 2004 | 1347 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 33 | 0.080 |
Why?
|
| Biological Availability | 2 | 2009 | 16 | 0.080 |
Why?
|
| Mannose-Binding Lectins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2008 | 19 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 38 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2006 | 114 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2009 | 18 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 13 | 0.080 |
Why?
|
| Carbohydrate Sequence | 2 | 2011 | 5 | 0.080 |
Why?
|
| Catalysis | 2 | 2009 | 16 | 0.080 |
Why?
|
| Fasciola hepatica | 1 | 2008 | 1 | 0.080 |
Why?
|
| Fascioliasis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2008 | 10 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2008 | 10 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2008 | 17 | 0.080 |
Why?
|
| Genes, Helminth | 2 | 2009 | 2 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2005 | 21 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 15 | 0.070 |
Why?
|
| Mitosporic Fungi | 1 | 2008 | 2 | 0.070 |
Why?
|
| Yeasts | 1 | 2008 | 3 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 120 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 2 | 2009 | 2 | 0.070 |
Why?
|
| Exons | 2 | 2009 | 33 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 14 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 1 | 0.070 |
Why?
|
| RNA, Helminth | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sex Differentiation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 8 | 0.070 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 5 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 36 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 33 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 229 | 0.070 |
Why?
|
| Immunization | 2 | 2022 | 17 | 0.070 |
Why?
|
| Microglia | 1 | 2008 | 136 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2008 | 79 | 0.070 |
Why?
|
| Markov Chains | 1 | 2006 | 30 | 0.070 |
Why?
|
| Depression, Chemical | 1 | 2006 | 4 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 5 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 4 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 6 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 14 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 34 | 0.060 |
Why?
|
| Spleen | 1 | 2006 | 34 | 0.060 |
Why?
|
| Parasite Egg Count | 2 | 2003 | 2 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 61 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 2 | 2002 | 3 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 456 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 1 | 0.060 |
Why?
|
| Peyer's Patches | 1 | 2005 | 1 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2005 | 5 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 34 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 2005 | 2 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 30 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2005 | 105 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2005 | 82 | 0.060 |
Why?
|
| Limulus Test | 1 | 2004 | 4 | 0.060 |
Why?
|
| Half-Life | 1 | 2004 | 11 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2004 | 58 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 17 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 25 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2004 | 15 | 0.060 |
Why?
|
| Electrons | 1 | 2004 | 16 | 0.060 |
Why?
|
| Phagocytes | 2 | 2018 | 12 | 0.060 |
Why?
|
| Linear Models | 1 | 2004 | 238 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 5 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 6 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 12 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 15 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 9 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 155 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2023 | 12 | 0.050 |
Why?
|
| Glycogen | 1 | 2023 | 16 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 127 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 11 | 0.050 |
Why?
|
| Aorta | 1 | 2023 | 14 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2003 | 242 | 0.050 |
Why?
|
| Peroxiredoxin III | 1 | 2002 | 1 | 0.050 |
Why?
|
| Purines | 1 | 2002 | 21 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 4 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 259 | 0.050 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2002 | 1 | 0.050 |
Why?
|
| Poly C | 1 | 2002 | 1 | 0.050 |
Why?
|
| Poly I | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sizofiran | 1 | 2002 | 1 | 0.050 |
Why?
|
| U937 Cells | 1 | 2002 | 1 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 2 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2023 | 42 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 19 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 7 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 92 | 0.050 |
Why?
|
| Glutaredoxins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Binding Sites | 1 | 2002 | 62 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 292 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 321 | 0.050 |
Why?
|
| Disease Resistance | 1 | 2022 | 1 | 0.050 |
Why?
|
| Aluminum Hydroxide | 1 | 2022 | 1 | 0.050 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 1 | 0.050 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2022 | 1 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 8 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 8 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2022 | 18 | 0.050 |
Why?
|
| Immune System | 1 | 2022 | 14 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 17 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2021 | 5 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 19 | 0.050 |
Why?
|
| Biofilms | 1 | 2021 | 16 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2002 | 109 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2022 | 67 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2022 | 52 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 82 | 0.050 |
Why?
|
| Zebrafish | 1 | 2021 | 18 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 85 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 61 | 0.050 |
Why?
|
| Biopolymers | 1 | 2021 | 6 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2020 | 20 | 0.050 |
Why?
|
| Vibrio | 1 | 2020 | 2 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2020 | 10 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2020 | 9 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2020 | 10 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 2 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2020 | 10 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 80 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 29 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 31 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 51 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 41 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 3 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2019 | 11 | 0.040 |
Why?
|
| Ischemia | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cell Count | 1 | 2019 | 75 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 51 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 42 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2020 | 170 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2018 | 2 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2018 | 2 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2018 | 4 | 0.040 |
Why?
|
| Pneumonia | 1 | 2019 | 72 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 122 | 0.040 |
Why?
|
| Mycoses | 2 | 2008 | 17 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 7 | 0.040 |
Why?
|
| Respiratory Burst | 1 | 2018 | 16 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2018 | 30 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 15 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2018 | 114 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2009 | 19 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2008 | 10 | 0.030 |
Why?
|
| Zymosan | 2 | 2008 | 5 | 0.030 |
Why?
|
| Syk Kinase | 2 | 2008 | 9 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2008 | 51 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2008 | 134 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2015 | 1 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 2 | 0.030 |
Why?
|
| Electrochemistry | 1 | 2015 | 42 | 0.030 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 1 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Malaria | 1 | 2015 | 4 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 155 | 0.030 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 3 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 5 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 600 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 40 | 0.030 |
Why?
|
| Nitrosation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 37 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 11 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2013 | 14 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2013 | 1 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 15 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2013 | 13 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 683 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 28 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 64 | 0.030 |
Why?
|
| Hemin | 1 | 2012 | 1 | 0.030 |
Why?
|
| Methemoglobin | 1 | 2012 | 1 | 0.030 |
Why?
|
| Malaria, Falciparum | 1 | 2012 | 2 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 33 | 0.020 |
Why?
|
| Skin | 1 | 2013 | 99 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 13 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 20 | 0.020 |
Why?
|
| Sheep | 1 | 2011 | 19 | 0.020 |
Why?
|
| Animal Structures | 1 | 2011 | 1 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 335 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 305 | 0.020 |
Why?
|
| Selenium | 1 | 2009 | 9 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2009 | 8 | 0.020 |
Why?
|
| DNA | 1 | 2009 | 104 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 30 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 9 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Glycosylation | 1 | 2008 | 17 | 0.020 |
Why?
|
| Chemokines | 1 | 2008 | 18 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Androstadienes | 1 | 2007 | 6 | 0.020 |
Why?
|
| Chromones | 1 | 2007 | 7 | 0.020 |
Why?
|
| Morpholines | 1 | 2007 | 12 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 98 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Apoptosis | 1 | 2007 | 190 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 75 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 89 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 166 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 63 | 0.010 |
Why?
|
| Genomic Library | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 36 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 7516 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 85 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 7 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 7 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 44 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 2172 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 8541 | 0.010 |
Why?
|